Trial Profile
Estimation of TKI Therapy Sensitivity Model for Renal Carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2019
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Pharmacodynamics; Pharmacogenomic
- 04 Jul 2018 New trial record